Medinova Diagnostic Services Ltd vs Cipla Ltd
A side-by-side comparison of Medinova Diagnostic Services Ltd (246883) and Cipla Ltd (CIPLA) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
Medinova Diagnostic Services Ltd and Cipla Ltd are evenly matched on the numbers (6–6, 2 tied). The breakdown below shows where each one wins.
Valuation
How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
How efficiently each company turns capital and sales into profit. Higher is better.
Growth
Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- − ["The company has delivered a poor sales growth of 5.66% over past five years."]
- + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 25.7%"]
- − ["The company has delivered a poor sales growth of 8.01% over past five years.", "Promoter holding has decreased over last 3 years: -4.26%"]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.